Gnosis Pharmaceuticals Private Limited

Pharmaceutical company with manufacturing facility and contract manufacturing services.

2005 | Delhi (India) | Active
Last Updated:

Gnosis Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.75 Cr
  • Paid Up Capital ₹ 1.57 Cr
  • Company Age 20 Year, 25 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 30.33 Cr
  • Satisfied Charges ₹ 15.48 Cr
  • Revenue Growth 18.21%
  • Profit Growth 143.33%
  • Ebitda 34.63%
  • Net Worth 20.44%
  • Total Assets 38.20%

About Gnosis Pharmaceuticals

Gnosis Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 March 2005 and has a history of 20 years. Its registered office is in Delhi, India.

The Corporate was formerly known as Kaizen Healthcare Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.57 Cr.

The company currently has active open charges totaling ₹30.33 Cr. The company has closed loans amounting to ₹15.48 Cr, as per Ministry of Corporate Affairs (MCA) records.

Ramesh Khurana, Rajesh Khurana, and Surendra Yadav serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231DL2005PTC134162

  • Company No.

    134162

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    17 Mar 2005

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

What products or services does Gnosis Pharmaceuticals Private Limited offer?

Gnosis Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Pharmaceutical Medicine, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Psoriasis Ointment, Anti Infective Drugs & Medicines, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops.

Company report

Gnosis Pharmaceuticals Private Limited

Explore comprehensive data for Gnosis Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Gnosis Pharmaceuticals?

Board Members (3)

NameDesignationAppointment DateStatus
Ramesh Khurana Country flag representing In Director 26-Nov-2011Current
Rajesh Khurana Country flag representing In Director 26-Nov-2011Current
Surendra Yadav Country flag representing In Director 26-Jun-2024Current

Financial Performance of Gnosis Pharmaceuticals.

Gnosis Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 18.21% increase. The company also saw a substantial improvement in profitability, with a 143.33% increase in profit. The company's net worth Soared by an impressive increase of 20.44%.

Gnosis Pharmaceuticals revenue growth over time
Gnosis Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
18.21%
Revenue from Operations
18.35%
Total Assets
38.20%
Profit or Loss
143.33%
Net Worth
20.44%
EBITDA
34.63%

What is the Ownership and Shareholding Structure of Gnosis Pharmaceuticals?

In 2024, Gnosis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹30.33 Cr

Satisfied Charges

₹15.48 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 28.95 Cr
  • Tata Capital Housing Finance Limited : 1.08 Cr
  • Director Of Industries : 0.30 Cr

Latest Charge Details

DateLenderAmountStatus
07 Mar 2024Hdfc Bank Limited₹2.00 MOpen
10 Dec 2021Hdfc Bank Limited₹2.50 MOpen
10 Dec 2021Hdfc Bank Limited₹2.50 MOpen
21 Nov 2020Hdfc Bank Limited₹28.25 CrOpen
13 Jul 2018Tata Capital Housing Finance Limited₹1.08 CrOpen

How Many Employees Work at Gnosis Pharmaceuticals?

Gnosis Pharmaceuticals has a workforce of 309 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Gnosis Pharmaceuticals Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gnosis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnosis Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Gnosis Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Gnosis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 28.25 Cr registered on 21 Nov 2020 with Charge ID 100418138 was modified on 19 Aug 2024.

  • Director Appointment

    Surendra Kumar Yadav was appointed as a Director was appointed as a Director on 26 Jun 2024 & has been associated with this company since 9 months 16 days .

  • Balance Sheet

    Gnosis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100880638 was registered on 07 Mar 2024.

  • Charges

    A charge registered on 29 May 2019 via Charge ID 100270199 with Others was fully satisfied on 01 Mar 2023.

Frequently asked questions

  • What is the Incorporation or founding date of Gnosis Pharmaceuticals Private Limited?

    Gnosis Pharmaceuticals Private Limited was incorporated on 17 Mar 2005.

  • What is authorized share capital and paid-up capital of Gnosis Pharmaceuticals Private Limited?

    The authorized share capital of Gnosis Pharmaceuticals Private Limited is ₹ 1.75 Cr and paid-up capital is ₹ 1.57 Cr.

  • Who are the current board members & directors of Gnosis Pharmaceuticals Private Limited?

    Currently 3 directors are associated with Gnosis Pharmaceuticals Private Limited.

    • Ramesh Khurana
    • Rajesh Kumar Khurana
    • Surendra Kumar Yadav

  • What is the registered address of Gnosis Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Gnosis Pharmaceuticals Private Limited is House No. B-102 First Floor Pushpanjali Enclave Pitampura India, New Delhi, 110034.

  • What is the corporate identification number (CIN) and company number of Gnosis Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Gnosis Pharmaceuticals Private Limited is U24231DL2005PTC134162 and the company number is 134162 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Gnosis Pharmaceuticals Private Limited?

    The Official website of Gnosis Pharmaceuticals Private Limited is https://www.gnosispharma.com

  • What has been the recent revenue trend for Gnosis Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Gnosis Pharmaceuticals Private Limited has risen by 18.21%.

  • How many employees does Gnosis Pharmaceuticals Private Limited currently have?

    As Per 2024 financial reports, 309 employees are currently employed by Gnosis Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Gnosis Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Gnosis Pharmaceuticals Private Limited has experienced an upsurge of 20.44%.

  • What are the total open charges for Gnosis Pharmaceuticals Private Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Gnosis Pharmaceuticals Private Limited amount to ₹ 30.33 Cr.

  • When was the last Balance Sheet of Gnosis Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Gnosis Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development